Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1991
10/20/1991CA2040036A1 Essentially monomeric normal serum albumin (human)
10/19/1991WO1991016352A1 A method for the preparation of pyridoxylated hemoglobin
10/19/1991WO1991016078A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/19/1991CA2079006A1 Method for the preparation of pyridoxylated hemoglobin
10/19/1991CA2058985A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/17/1991WO1991016348A1 Interleukin-4 binding protein-gamma
10/17/1991WO1991015770A1 Therapeutic uses of actin-binding compounds
10/17/1991WO1991015603A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
10/17/1991WO1991015586A1 Improvements relating to the detection of viruses
10/17/1991WO1991015584A1 Trypanosoma cruzi recombinant antigens and synthetic peptides for utilization in the immunological diagnosis of chagas disease
10/17/1991WO1991015581A1 Walk-through mutagenesis
10/17/1991WO1991015580A1 Gene therapy for cell proliferative diseases
10/17/1991WO1991015577A1 INTERLEUKIN 1 beta PROTEASE
10/17/1991WO1991015576A1 Treatment of thrombotic events
10/17/1991WO1991015514A1 Oxidation resistant thrombomodulin analogs
10/17/1991WO1991015513A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides
10/17/1991WO1991015511A1 Hybrid calcitonin
10/17/1991WO1991015509A1 Methods and formulations for stabilizing fibroblast growth factor
10/17/1991WO1991015508A1 Human splenopentine derivatives and process for producing them
10/17/1991WO1991015236A1 Treatment of autoimmune diseases
10/17/1991WO1991015235A1 t-PA ENHANCER PROFILE
10/17/1991WO1991015234A1 Recombinant bile salt activated lipases
10/17/1991WO1991015233A1 Use of protease nexin-i to mediate wound healing
10/17/1991WO1991015232A1 A cd43 fragment which binds to autoantibodies produced by hiv infected individuals
10/17/1991WO1991015231A1 Wound healing
10/17/1991WO1991015227A1 Method and compositions for treating injury
10/17/1991WO1991015225A1 Multiple sclerosis t-cell receptor
10/17/1991WO1991015224A1 Inhibition of disease associated with immunodeficiency virus infection
10/17/1991WO1991015221A1 Inhibition of allograft and concordant xenograft rejection
10/17/1991WO1991015219A1 Method of treatment with hsp70
10/17/1991WO1991015204A2 METHOD AND AGENTS FOR THE SELECTIVE REDUCTION OF Lp(a)
10/17/1991WO1991015127A1 High-protein high-viscosity alimentary food composition
10/17/1991WO1991015121A1 Method for treating fungal infection
10/17/1991WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
10/17/1991WO1991006658A3 Infective protein delivery system
10/17/1991WO1991000916A3 Receptors for fibroblast growth factors
10/17/1991CA2080233A1 Hybrid calcitonin
10/17/1991CA2079903A1 Gene therapy for cell proliferative diseases
10/17/1991CA2079813A1 Method of treatment with hsp70
10/17/1991CA2079783A1 Use of protease nexin-i to mediate wound healing
10/17/1991CA2079600A1 Interleukin-4 binding protein-gamma
10/17/1991CA2018630A1 Use of a polypeptide having human interleukine 2 activity to prepare a pharmaceutical compound for the treatment of primary cancer of the plevra
10/16/1991EP0452299A1 Method and composition for stimulating the growth of nerve processes
10/16/1991EP0452257A2 Novel platelet-aggregation inhibitors
10/16/1991EP0451972A1 Utilization of enzymes
10/16/1991EP0451957A2 Cyclohexapeptide compound
10/16/1991EP0451903A2 Composition for the regulation of hair growth
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451867A1 Parathyroid hormone antagonists
10/16/1991EP0451791A2 Long acting liposome compositions containing peptid drugs and method for their preparation
10/16/1991EP0451763A2 Peptide derivatives with amphiphatic properties, intermediates thereof and liposomes and films comprising said derivatives
10/16/1991EP0451760A1 Nitrato alkanoic acid derivatives and method for their production
10/16/1991EP0451612A1 Anti-oncostatin M monoclonal antibodies
10/16/1991EP0451611A2 Human hematopoietic stem cell
10/16/1991EP0451550A2 Seroreactive epitopes of human Papillomavirus (HPV) 16 proteins
10/16/1991EP0451547A1 1,4,8-Triazacyclotridecane derivatives having prolyl endopeptidase inhibiting activity
10/16/1991EP0451486A1 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T
10/16/1991EP0451439A1 Use of a cartilage-inducing factor (CIF) for treating hematopoietic or lymphopoietic disorders
10/16/1991EP0451436A2 Method of curing and preventing obesity by alpha-amylase inhibitor
10/16/1991EP0451357A1 Pathogenesis factors of dermatophytes
10/16/1991EP0451299A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
10/16/1991EP0451211A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs
10/16/1991EP0451206A1 Receptor transcription-repression activity compositions and methods
10/16/1991EP0434744A4 Serum immunoregulatory polypeptide and uses therefor
10/16/1991EP0423193A4 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human
10/16/1991EP0229810B1 Protection of proteins and the like
10/16/1991EP0193561B1 Monoclonal antibodies against metal chelates
10/16/1991CN1055389A Novel proteins with oncostatin m activity and process for their preparation
10/16/1991CN1055293A Stable compositions for parenteral administration and method of making same
10/15/1991US5057603 Peptides having ANF activity
10/15/1991US5057598 Monoclonal antibodies reactive with endotoxin core
10/15/1991US5057523 Water soluble bactericide
10/15/1991US5057520 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
10/15/1991US5057497 Oral method for the maintenance of healthy gingival tissues using TRF
10/15/1991US5057496 Dipeptide compounds containing histidine or n-methyl histidine processes for their preparation and compositions containing them
10/15/1991US5057495 Atrial hypotensive peptide
10/15/1991US5057494 Method for preventing tissue damage after an ischemic episode
10/15/1991US5057493 Cyclic peptides, also fungicides
10/15/1991US5057426 Method for separating long-chain nucleic acids
10/15/1991US5057423 Method for the preparation of pure LAK-active lymphocytes
10/15/1991US5057417 Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
10/15/1991US5057324 Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof
10/15/1991CA1290692C Substrate composition for treating atherosclerosis
10/15/1991CA1290691C Methods of treating bone diseases by administration of a cysteine proteinase inhibitor
10/15/1991CA1290688C Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
10/15/1991CA1290687C Process for treatment of allergies
10/14/1991CA2080002A1 Composition for macrophage activation
10/13/1991WO1991016341A1 Peptide derivatives
10/13/1991CA2059302A1 Peptide derivatives
10/13/1991CA2040264A1 Parathyroid hormone antagonists
10/13/1991CA2040237A1 Long-acting liposome peptide pharmaceutical products and processes for the preparation thereof
10/13/1991CA2040130A1 Composition for the regulation of hair growth
10/11/1991WO1991015507A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991WO1991015506A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991WO1991015246A1 Calcitonin gene related peptide for the treatment of undescended testicles
10/11/1991CA2080354A1 Calcitonin gene related peptide for the treatment of undescended testicles
10/11/1991CA2080228A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991CA2080227A1 Phosphonopeptides with collagenase inhibiting activity
10/10/1991WO1992017583A1 Isolated viral protein cytokine antagonists
10/10/1991WO1991015503A1 T-cell suppressor protein
1 ... 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 ... 3163